CA2054189A1 - Stable ascorbic acid compositions - Google Patents

Stable ascorbic acid compositions

Info

Publication number
CA2054189A1
CA2054189A1 CA2054189A CA2054189A CA2054189A1 CA 2054189 A1 CA2054189 A1 CA 2054189A1 CA 2054189 A CA2054189 A CA 2054189A CA 2054189 A CA2054189 A CA 2054189A CA 2054189 A1 CA2054189 A1 CA 2054189A1
Authority
CA
Canada
Prior art keywords
ascorbic acid
water
composition
carrier
acid compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2054189A
Other languages
French (fr)
Other versions
CA2054189C (en
Inventor
Douglas Darr
Sheldon R. Pinnell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Duke University
Original Assignee
Douglas Darr
Sheldon R. Pinnell
Duke University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23329228&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2054189(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Douglas Darr, Sheldon R. Pinnell, Duke University filed Critical Douglas Darr
Publication of CA2054189A1 publication Critical patent/CA2054189A1/en
Application granted granted Critical
Publication of CA2054189C publication Critical patent/CA2054189C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/39Derivatives containing from 2 to 10 oxyalkylene groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/676Ascorbic acid, i.e. vitamin C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/731Cellulose; Quaternized cellulose derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/51Chelating agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/004Aftersun preparations

Abstract

A stable topical composition consists essentially of at least about 1 wt.% L-ascobic acid, preferably from about 3 to 20 wt.
% L-ascorbic acid, and more preferably about 5 to 10 wt% L-ascorbic acid in water and a carrier for topical application is disclosed. Such a composition appears to allow ready penetration into the skin and retards the damage caused by ultraviolet tight.
Any composition containing at least about 1 wt. % L-ascorbic acid is expected to have beneficial effects, with the concentration of L-ascorbic acid being primarily limited by its solubility in the water/carrier system. The ratio of water to carrier is at least 1:1, and more preferably from 2:1 to 10:1, and the pH of the composition is no more than 3.0 to 3:5, preferably no more than about 2.5.
CA002054189A 1989-04-17 1990-04-16 Stable ascorbic acid compositions Expired - Lifetime CA2054189C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US339,488 1989-04-17
US07/339,488 US5140043A (en) 1989-04-17 1989-04-17 Stable ascorbic acid compositions
PCT/US1990/001968 WO1990012572A1 (en) 1989-04-17 1990-04-16 Stable ascorbic acid compositions

Publications (2)

Publication Number Publication Date
CA2054189A1 true CA2054189A1 (en) 1990-10-18
CA2054189C CA2054189C (en) 2000-11-21

Family

ID=23329228

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002054189A Expired - Lifetime CA2054189C (en) 1989-04-17 1990-04-16 Stable ascorbic acid compositions

Country Status (11)

Country Link
US (1) US5140043A (en)
EP (1) EP0486499B1 (en)
JP (1) JP3708540B2 (en)
AT (1) ATE156355T1 (en)
AU (1) AU647699B2 (en)
CA (1) CA2054189C (en)
DE (1) DE69031219T2 (en)
DK (1) DK0486499T3 (en)
ES (1) ES2104605T3 (en)
HK (1) HK1001834A1 (en)
WO (1) WO1990012572A1 (en)

Families Citing this family (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622690A (en) * 1990-04-05 1997-04-22 Nurture, Inc. Seed-derived proteinaceous compositions for reduction of sunburn cell formation
AU662505B2 (en) * 1990-12-06 1995-09-07 Leslie Binshyang Soong Substance that can stop bleeding in surgical, medical and dental uses/substance powder 001 that can stop bleeding during surgery, after surgery, medicine, dentistry or any bleeding due to any causes
US5308621A (en) * 1991-02-18 1994-05-03 Commonwealth Scientific And Industrial Research Organisation Ascorbic acid composition and transdermal administration method
US5523077A (en) * 1992-02-06 1996-06-04 Yale University Composition and method for whitening skin
ES2151498T3 (en) * 1993-01-19 2001-01-01 Nicholas V Dr Perricone COMPOSITIONS FOR TOPICAL APPLICATION TO THE SKIN FOR THE TREATMENT AND / OR PREVENTION OF THE INJURY IN THE SKIN INDUCED BY RADIATION.
US5516793A (en) * 1993-04-26 1996-05-14 Avon Products, Inc. Use of ascorbic acid to reduce irritation of topically applied active ingredients
US5759548A (en) * 1993-11-30 1998-06-02 Lxr Biotechnology Inc. Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
US5935584A (en) * 1994-01-13 1999-08-10 Elizabeth Arden Company Vitamin C delivery system
US5455035A (en) * 1994-01-13 1995-10-03 Elizabeth Arden Company, Division Of Conopco, Inc. Clear two-phase cosmetic composition
FR2718018B1 (en) * 1994-04-05 1996-04-26 Oreal Cosmetic and / or dermatological composition with hydrophilic support and vitamin C mixable extemporaneously.
US5470874A (en) * 1994-10-14 1995-11-28 Lerner; Sheldon Ascorbic acid and proanthocyanidine composition for topical application to human skin
EP0729746A1 (en) * 1995-02-28 1996-09-04 Unilever Plc Vitamin C delivery system
FR2737116B1 (en) * 1995-07-25 1997-08-22 Oreal STABLE COMPOSITION CONTAINING A WATER SENSITIVE COSMETIC AND / OR DERMATOLOGICAL ACTIVE
FR2737122B1 (en) * 1995-07-25 1997-09-12 Oreal STABLE COMPOSITION CONTAINING ASCORBIC ACID
US5843411A (en) * 1997-02-06 1998-12-01 Topix Pharmaceuticals Inc. Stabilization of ascorbic acid, ascorbic acid derivatives and/or extracts containing ascorbic acid for topical use
JPH09309833A (en) * 1996-05-22 1997-12-02 Toyo Hakko:Kk Active oxygen-suppressing composition and its production and hypotensive medicine
US5750123A (en) * 1996-06-28 1998-05-12 Chesebrough-Pond's Co., Division Of Conopco, Inc. Vitamin C delivery system
US6593456B1 (en) * 1996-11-06 2003-07-15 The Regents Of The University Of California Tumor necrosis factor receptor releasing enzyme
US20050191661A1 (en) * 1996-11-06 2005-09-01 Tetsuya Gatanaga Treatment of inflammatory disease by cleaving TNF receptors
BR9712900A (en) 1996-11-06 2000-11-28 Univ California Isolated tumor necrosis factor receptor-releasing enzyme, compositions comprising the enzyme and methods of using it
US5877209A (en) * 1996-11-07 1999-03-02 Yunis; Adel A. Hair follicle protective formulations
SE9604610D0 (en) * 1996-12-16 1996-12-16 Noviscens Ab Medical composition
US5906918A (en) * 1997-02-07 1999-05-25 Health Research Inc. Compositions and methods for measurement of oxidative DNA damage
US6495532B1 (en) * 1997-03-19 2002-12-17 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
US6037481A (en) * 1997-08-08 2000-03-14 Industria E Comercio De Cosmeticos Natura Ltda Process for stabilizing levogyre ascorbic acid (LAA), a stable aqueous LAA composition, a process for preparing a stable topical solution, an emulsion, a vitamin product, and a method for cosmetic, pharmaceutical or nutritional treatment
US6197317B1 (en) 1997-08-11 2001-03-06 Marvin E. Klein Composition and method for the treatment of skin
US5981578A (en) * 1997-09-15 1999-11-09 Alexandrides; Ariadne Increased solubilization and stable cosmetic preparations of ascorbic acid
US6132737A (en) * 1997-09-29 2000-10-17 Revlon Consumer Products Corporation Method for reducing sunburn cell formation with cosmetic compositions containing ascorbic acid
US6685965B1 (en) 1997-10-22 2004-02-03 Industria E Comercio De Cosmeticos Natura Ltda. Process for stabilizing levogyre ascorbic acid (laa), a stable aqueous laa composition, a process for preparing a stable topical solution, an emulsion, a vitamin product, and a method for cosmetic, pharmaceutical or nutritional treatment
US6194452B1 (en) 1997-11-07 2001-02-27 Howard Murad Stable pharmaceutical compositions including ascorbic acid and methods of using same
US6036946A (en) * 1997-12-24 2000-03-14 Shaklee Corporation Methods for protecting skin from damaging effects of ultraviolet light
US5980925A (en) * 1997-12-30 1999-11-09 Ethicon, Inc. High glycerin containing anti-microbial cleansers
US6110966A (en) * 1998-02-20 2000-08-29 Medi-Cell Laboratories, Inc. Triple action complex
US6809075B1 (en) 2000-05-30 2004-10-26 Connective Tissue Imagineering Llc Elastin peptide analogs and uses of same incombination with skin enhancing agents
US6962904B1 (en) * 1998-03-13 2005-11-08 Connective Tissue Imagineering Elastin peptide analogs and uses thereof
US6949528B1 (en) 1998-03-18 2005-09-27 Goddard John G Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
US6703030B2 (en) 1998-06-16 2004-03-09 Marvin E. Klein Amino fruit acid composition and method for the treatment of skin
US6146664A (en) * 1998-07-10 2000-11-14 Shaklee Corporation Stable topical ascorbic acid compositions
US6103267A (en) * 1998-07-27 2000-08-15 Sunsmart, Inc. Stabilized ascorbic acid, composition, and method of use
US6207694B1 (en) 1998-07-27 2001-03-27 Howard Murad Pharmaceutical compositions and methods for managing scalp conditions
US6299889B1 (en) 1998-09-10 2001-10-09 Avon Products, Inc. Stable ascorbic acid preparation for topical use
US6110477A (en) * 1998-10-30 2000-08-29 Topix Pharmaceuticals Inc. Stabilization of ascorbic acid, ascorbic acid derivatives and/or extracts containing ascorbic acid for topical use
US6777389B1 (en) 1998-11-19 2004-08-17 Connective Tissue Imagineering Llc Cosmetic or dermatological use of 7-hydroxylated steroids in combination with elastin derived peptides
KR100297347B1 (en) * 1998-12-09 2001-08-07 이현순 A W/O type emulsion cosmetic composition containing the stabilized L-ascorbic acid and a method for preparing the same
US7816402B2 (en) * 1999-03-19 2010-10-19 Bioderm, Inc. Compositions and methods for the treatment of skin
US6217914B1 (en) 1999-03-19 2001-04-17 Bioderm, Inc. Ascorbic acid composition and method for treatment of aging or damaged skin
US6087393A (en) * 1999-06-10 2000-07-11 Igen, Inc. Stabilized vitamin C formulations
BRPI0003166B1 (en) * 1999-07-16 2015-08-25 Natura Cosmeticos Sa Process for stabilizing antioxidant compounds, and aqueous compositions
US20060063738A1 (en) * 2000-02-28 2006-03-23 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
AU2001247264B2 (en) * 2000-03-03 2005-08-18 Australian Importers, Ltd. Micronized vitamin C formulation
US7101563B1 (en) 2000-03-03 2006-09-05 Australian Importers, Ltd. Micronized vitamin C formulation
US20050003023A1 (en) * 2002-06-28 2005-01-06 Meisner Lorraine Faxon Topical composition for the treatment of psoriasis and related skin disorders
US6440465B1 (en) * 2000-05-01 2002-08-27 Bioderm, Inc. Topical composition for the treatment of psoriasis and related skin disorders
CN1189159C (en) * 2000-05-05 2005-02-16 欧莱雅 Micro-capsule contg. water soluble beauty-care activity component water nuclear, and composition contg. same
US6794362B1 (en) * 2000-05-30 2004-09-21 Connective Tissue Imagineering Llc Asparagine containing elastin peptide analogs
BR0109780A (en) * 2000-09-08 2003-01-21 Vivier Pharma Inc Stabilized ascorbic acid solutions; use of them; process for obtaining them and formulations comprising the same
US6576248B1 (en) 2000-09-11 2003-06-10 Avon Products, Inc. Pigmented vitamin C composition
US6583184B1 (en) 2000-11-27 2003-06-24 Avon Products, Inc. Compositions having comfrey and methods for reducing retinoid-induced skin irritation
KR100836032B1 (en) * 2002-03-26 2008-06-09 (주)아모레퍼시픽 Multi-hollow polymer microcapsules containing L-ascorbic acid, the process for preparation of the same and the cosmetic composition thereof
US7241808B2 (en) * 2002-05-01 2007-07-10 Marvin Klein Composition for treatment of skin and method for stabilizing the composition
US7482116B2 (en) * 2002-06-07 2009-01-27 Dna Genotek Inc. Compositions and methods for obtaining nucleic acids from sputum
KR100879133B1 (en) 2002-12-23 2009-01-19 주식회사 엘지생활건강 Non water-soluble whitening makeup composition and method for preparing therof
ATE432740T1 (en) * 2004-01-13 2009-06-15 Oreal Usa Creative Inc STABILIZED ASCORBIC ACID COMPOSITIONS AND METHODS THEREOF
US7566693B2 (en) * 2005-02-22 2009-07-28 Human Matrix Sciences, Llc Elastin protective polyphenolics and methods of using the same
US8114829B2 (en) * 2005-02-22 2012-02-14 Human Matrix Sciences, Llc Elastin protective polyphenolics and methods of using the same
CA2600758C (en) * 2005-03-16 2016-01-12 Dna Genotek Inc. Compositions and method for storage of nucleic acid from bodily fluids
US8642578B2 (en) 2005-03-29 2014-02-04 Human Matrix Sciences, Llc Elastin protective polyphenolics and methods of using the same
US20070077220A1 (en) * 2005-09-30 2007-04-05 Ramirez Jose E Stable ascorbic acid compositions
DK1956969T3 (en) * 2005-12-09 2012-01-30 Dna Genotek Inc Container system for releasable storage of fabric
US20070269534A1 (en) * 2006-02-02 2007-11-22 Ramirez Jose E Methods of treating skin to enhance therapeutic treatment thereof
US20070178058A1 (en) * 2006-02-02 2007-08-02 Ramirez Jose E Methods of using stable ascorbic acid compositions
US20070225360A1 (en) * 2006-03-22 2007-09-27 L'oreal Anti-aging composition containing phloretin
US20080057138A1 (en) * 2006-09-06 2008-03-06 Telford Holdings Ltd. Restorative skin cream
US8415389B2 (en) * 2007-01-31 2013-04-09 John E. Kulesza Polyphenol-based composition, and methods and systems for its preparation
US8491212B2 (en) * 2008-03-17 2013-07-23 Laboratoire Naturel Paris, Llc Multi-functional applicator
US8881894B2 (en) * 2008-08-21 2014-11-11 Sonovia Holdings Llc Multiple-compartment applicator
US8034363B2 (en) * 2008-12-11 2011-10-11 Advanced Technologies And Regenerative Medicine, Llc. Sustained release systems of ascorbic acid phosphate
US20110166222A1 (en) * 2010-01-05 2011-07-07 Kaplan David L Vitamin c composition for use in the prevention and treatment of stretch marks, radiation dermatitis, and other skin conditions and methods of using the same
JP2012054306A (en) * 2010-08-31 2012-03-15 Tokyo Electron Ltd Manufacturing method of semiconductor device
US9068694B2 (en) 2010-09-22 2015-06-30 Philip J. Gordon Consultants, Inc. Method of controlling by-products of vitamin C degradation and improving package integrity shelf life
EP3928715A1 (en) 2011-06-19 2021-12-29 DNA Genotek, Inc. Devices, solutions and methods for sample collection
JP5955625B2 (en) * 2012-04-27 2016-07-20 御木本製薬株式会社 Skin preparation
CA2890177A1 (en) * 2012-11-08 2014-05-15 Summa Health System Vitamin c, vitamin k, a polyphenol, and combinations thereof for wound healing
CN110785161B (en) 2017-06-23 2023-06-20 宝洁公司 Compositions and methods for improving the appearance of skin
CN111971043A (en) * 2018-03-30 2020-11-20 日本乐敦制药株式会社 Ascorbic acid and/or external composition containing salt thereof
KR20210011964A (en) 2018-07-03 2021-02-02 더 프록터 앤드 갬블 캄파니 How to treat a skin condition
CN112638166A (en) * 2018-08-09 2021-04-09 不二制油集团控股株式会社 Oil and fat composition
WO2020067132A1 (en) * 2018-09-25 2020-04-02 ロート製薬株式会社 Topical composition containing ascorbic acid and/or salt thereof
DE102018008512A1 (en) 2018-10-27 2020-04-30 Ilma biochem GmbH Production, composition and application of preparations in a two-chamber application device for neutralizing and inactivating oxidizing, corrosive and irritating chemicals on the skin
FR3090330B1 (en) 2018-12-20 2020-12-04 Oreal Aqueous composition comprising capsules based on gelled oil containing an active agent sensitive to oxygen
US20220313588A1 (en) * 2019-09-11 2022-10-06 Amorepacific Corporation Additive composition for preventing vitamin c precipitation
FR3105735B1 (en) 2019-12-26 2023-07-07 Oreal Composition comprising ascorbic acid
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
JP2023528616A (en) 2020-06-01 2023-07-05 ザ プロクター アンド ギャンブル カンパニー Method for improving skin penetration of vitamin B3 compounds
WO2022130291A1 (en) 2020-12-17 2022-06-23 L'oreal Hydroglycolic cosmetic composition with a high active content
FR3118874B1 (en) 2021-01-21 2024-01-12 Oreal COSMETIC COMPOSITION FOR METAL SEQUESTRATION
WO2022130292A1 (en) 2020-12-17 2022-06-23 L'oreal Metal sequestering cosmetic composition
FR3121357A1 (en) 2021-03-31 2022-10-07 L'oreal HYDROGLYCOLIC COSMETIC COMPOSITION WITH A HIGH CONTENT OF ACTIVE PRINCIPLES
FR3117803B1 (en) 2020-12-18 2022-12-09 Oreal Composition comprising aqueous gelling agents, surfactant and ascorbic acid
FR3117847B1 (en) 2020-12-18 2023-11-24 Oreal Composition comprising aqueous gelling agents, surfactants and ascorbic acid
WO2022149055A1 (en) 2021-01-05 2022-07-14 L'oreal Organic uva filter-stabilized antioxidant composition
FR3121043B1 (en) 2021-03-29 2024-03-08 Oreal ANTIOXIDANT COMPOSITION STABILIZED BY AN ORGANIC UVA FILTER
FR3130603A1 (en) * 2021-12-20 2023-06-23 L'oreal Aqueous cosmetic composition with ascorbic acid and urea

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2161651A (en) * 1934-12-27 1939-06-06 Elliott J Roberts Manufacture of finely divided precipitates
US2249903A (en) * 1935-01-26 1941-07-22 Winthrop Chem Co Inc Stable aqueous solution of ascorbic acid
US2400171A (en) * 1935-09-26 1946-05-14 Frances R Ruskin Stabilized metal ascorbates
US2134246A (en) * 1936-07-09 1938-10-25 Hoffmann La Roche Stable solutions of ascorbic acid salts of histidine and process for the manufacture of same
US2140989A (en) * 1936-07-30 1938-12-20 Winthrop Chem Co Inc Molecular compounds and a process of preparing them
US2132662A (en) * 1937-04-08 1938-10-11 Abbott Lab Aliphatic amine salts of cevitamic acid
US2150140A (en) * 1937-04-24 1939-03-07 Hoffmann La Roche Derivatives of ascorbic acid having an antiscorbutic action and process for the manufacture of same
US2297212A (en) * 1938-02-10 1942-09-29 Gockel Heinrich Stable vitamin c and process for preparing the same
US2294937A (en) * 1938-02-26 1942-09-08 Simon L Ruskin Cevitamate compound
US2165184A (en) * 1938-08-31 1939-07-04 Pfizer Charles & Co Process for producing ascorbic acid
US2187467A (en) * 1939-02-11 1940-01-16 Lilly Co Eli Cevitamate solution
US2442461A (en) * 1944-03-09 1948-06-01 Hoffmann La Roche Stable solutions of calcium ascorbate
US2585580A (en) * 1947-06-12 1952-02-12 Opplt Jan Stabilizing ascorbic acid with thio-sugars
US2721161A (en) * 1951-10-23 1955-10-18 American Home Prod Ascorbic acid preparation
US4294852A (en) * 1973-11-01 1981-10-13 Johnson & Johnson Skin treating compositions
US4372874A (en) * 1976-09-13 1983-02-08 Modrovich Ivan Endre Stabilization of hydrolysis prone labile organic reagents in liquid media
US4199469A (en) * 1978-06-21 1980-04-22 Feldmann Chemie Composition and method for cleaning drinking water tanks
US4367157A (en) * 1979-05-10 1983-01-04 Sherman Laboratories, Inc. Soft contact lens ambient temperature disinfectant solution containing ascorbic acid or salt thereof
US4414202A (en) * 1980-02-19 1983-11-08 Silvetti Anthony N Composition for treatment of wounds
US4722936A (en) * 1983-05-05 1988-02-02 Joseph Jacob Deodorization vaginal products and catamenials
US4818521A (en) * 1985-04-18 1989-04-04 Sunstar Kabushiki Kaisha Emulsion cosmetic stably containing vitamin C
US4983382A (en) * 1987-01-27 1991-01-08 Avon Products, Inc. Cosmetic preparation incorporating stabilized ascorbic acid
NZ219636A (en) * 1987-03-16 1989-06-28 Donald Sinclair Hamilton Cream containing powdered ascorbate
US4954332A (en) * 1987-10-22 1990-09-04 The Procter & Gamble Company Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent
US4946671A (en) * 1987-10-22 1990-08-07 The Procter & Gamble Company Photoprotection compositions comprising sorbohydroxamic acid and an anti-inflammatory agent
US4847071A (en) * 1987-10-22 1989-07-11 The Procter & Gamble Company Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent
US4938969A (en) * 1988-11-14 1990-07-03 Milor Scientific, Ltd. Method for the treatment of aging or photo-damaged skin
JPH06337087A (en) * 1993-05-27 1994-12-06 Takasago Thermal Eng Co Ltd Branch pipe connecting method and bonnet connecting method

Also Published As

Publication number Publication date
EP0486499A4 (en) 1993-06-16
ATE156355T1 (en) 1997-08-15
HK1001834A1 (en) 1998-07-10
US5140043A (en) 1992-08-18
JPH04507089A (en) 1992-12-10
ES2104605T3 (en) 1997-10-16
WO1990012572A1 (en) 1990-11-01
JP3708540B2 (en) 2005-10-19
CA2054189C (en) 2000-11-21
DK0486499T3 (en) 1998-03-16
AU647699B2 (en) 1994-03-24
DE69031219T2 (en) 1998-01-22
AU5523990A (en) 1990-11-16
EP0486499B1 (en) 1997-08-06
DE69031219D1 (en) 1997-09-11
EP0486499A1 (en) 1992-05-27

Similar Documents

Publication Publication Date Title
CA2054189A1 (en) Stable ascorbic acid compositions
EP0304627A3 (en) Antimicrobial active aromatic compositions
DE69329781D1 (en) CONCENTRATED, BIOAVAILABLE CALCIUM SOURCE
CA2366996A1 (en) Ascorbic acid composition and method for treatment of aging or damaged skin
EP0165656A3 (en) Improved stability oxygen scavenger compositions and method of use thereof
EP0156924A4 (en) Chemically active composition containing ferrous ion.
AU3369299A (en) Stable concentrated rare earth carboxylate liquids
MY101600A (en) An agricultural composition with reduced toxicity to fishes and shellfishes.
CA2016470A1 (en) Pharmaceutical preparation and method of treatment for liver dysfunction
ES8700054A1 (en) Improved germicide composition.
IE791107L (en) Anaerobic compositions
JPS5799521A (en) Solid composition containing bisacodyl
JPS5585511A (en) Permanent wave composition
HK50094A (en) Skin detergent composition
MY110092A (en) Butyric acid derivatives
EP0837044A3 (en) Method of preparing a composition to be sprayed on plant leaves or fruits
DE2963545D1 (en) Pharmaceutical composition containing all-e- or 13-z-7,8-dehydro-retinoic acid and process for its preparation
JPS5576814A (en) Preservative solution for organ transplant
DE68905796T2 (en) AEROSOL PREPARATIONS CONTAINING CHROMOGLYCINE ACID SODIUM SALT.
AU621677B2 (en) Stable aqueous solutions of primycin, pharmaceutical and cosmetic compositions containing these solutions and process for preparing same
JPS5590517A (en) Water-containing gel
JPS57183780A (en) Beta-d-xylopyranoside compound
MY104606A (en) Aqueous high concentration composition of alpha-sulfofa -tty acid ester salt.
JPS5520717A (en) Saccharide-transfusing agent
EP0141414A3 (en) Hair tonic composition

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry